Agoracom: Small Cap Investment - Resverlogix Corp. - Re: New insights from this study -- Questions for scientists.

...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Reply New Message

Back To Forum List View

New insights from this study -- Questions for scientists.

golfyeti

Jun 08, 2022 11:18AM

Re: New insights from this study -- Questions for scientists.

golfyeti

Jun 08, 2022 11:27AM

Re: New insights from this study -- Questions for scientists.

golfyeti

Jun 08, 2022 11:59AM

Re: New insights from this study -- Questions for scientists.

BearDownAZ

Jun 08, 2022 12:06PM

Re: New insights from this study -- Questions for scientists.

BearDownAZ

Jun 08, 2022 12:18PM

Re: New insights from this study -- Questions for scientists.

golfyeti

Jun 08, 2022 12:23PM

Re: New insights from this study -- Questions for scientists.

KOO-KOO2

Jun 08, 2022 12:43PM

Re: New insights from this study -- Questions for scientists.

golfyeti

Jun 08, 2022 01:17PM

tada

Rank: President [?]

Points: 7687 [?]

Votes: 40 Score: 3.4 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: New insights from this study -- Questions for scientists.

in response to

Re: New insights from this study -- Questions for scientists.

golfyeti

posted on Jun 08, 2022 03:05PM

golfyeti - You May have to go back to the results of the 1st P1 dosing study trial to get the answers your looking for. I recall reading those results shortly after getting involved in this saga around 13 years ago.

tada

2 Recommendations

Re: New insights from this study -- Questions for scientists.

golfyeti

Jun 09, 2022 10:52AM

Re: New insights from this study -- Questions for scientists.

Buckeyes

Jun 09, 2022 11:23AM

Re: New insights from this study -- Questions for scientists.

tada

Jun 09, 2022 11:38AM

Re: New insights from this study -- Questions for scientists.